Evidence map›Paper›PMID 26056597›Full record

ReviewMolecular and cellular therapies2014

Neural stem cells: ready for therapeutic applications?

Simona Casarosa, Yuri Bozzi, Luciano Conti

Abstract readReview
In one paragraph

Review in Molecular and cellular therapies, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Luteolin Modulates Neural Stem Cells Fate Determination:Frontiers in cell and developmental biology · 2021
    Article
  18. Article
  19. Article
  20. 4D Self-Morphing Culture Substrate for Modulating Cell Differentiation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Simona CasarosaCenter for Integrative Biology, Università degli Studi di Trento, Via Sommarive 9, Povo-Trento, 38123 Italy.
Yuri BozziCenter for Integrative Biology, Università degli Studi di Trento, Via Sommarive 9, Povo-Trento, 38123 Italy.
Luciano ContiCenter for Integrative Biology, Università degli Studi di Trento, Via Sommarive 9, Povo-Trento, 38123 Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neural stem cells (NSCs) offer a unique and powerful tool for basic research and regenerative medicine. However, the challenges that scientists face in the comprehension of the biology and physiological function of these cells are still many. Deciphering NSCs fundamental biological aspects represents indeed a crucial step to control NSCs fate and functional integration following transplantation, and is essential for a safe and appropriate use of NSCs in injury/disease conditions. In this review, we focus on the biological properties of NSCs and discuss how these cells may be exploited to provide effective therapies for neurological disorders. We also review and discuss ongoing NSC-based clinical trials for these diseases.

Indexed as

Cell therapyNeural stem cellsNeurodegenerative diseasesNeurodevelopmental disordersNeuronPluripotent stem cells

Identifiers

PMID26056597
PMCPMC4452059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.